Piotech (SH:688072) Xin Lang Cai Jing·2025-04-30 12:35Group 1: Revenue Growth - In 2024, the company achieved revenue of 4.103 billion yuan, a year-on-year increase of 51.70% [1] - Revenue from thin film deposition equipment reached 3.863 billion yuan, up 50.29% year-on-year, with PECVD maintaining its core advantage and achieving record sales [1] - The company continued to maintain high growth in Q1 2025, with revenue of 709 million yuan, a year-on-year increase of 50.22% [1] Group 2: Profitability and R&D Investment - In 2024, the company's net profit attributable to shareholders was 688 million yuan, a year-on-year increase of 3.86%, while the net profit after deducting non-recurring items was 356 million yuan, up 14.10% [2] - R&D expenses for the year were 756 million yuan, an increase of 31.26% year-on-year, contributing to a decrease in gross margin [2] - The gross margin for 2024 was 41.69%, down 5.43 percentage points year-on-year, primarily due to the higher costs associated with new products and processes [2] Group 3: Order Backlog and Inventory - As of the end of 2024, the company had an order backlog of approximately 9.4 billion yuan, indicating strong demand [2] - Inventory at the end of Q1 2025 was 7.812 billion yuan, a year-on-year increase of 39.18%, with a 94% increase in shipped goods [2] - Contract liabilities reached 3.752 billion yuan, up 170.65% year-on-year, reflecting a robust order backlog [2] Group 4: Profit Forecast and Valuation - The company forecasts revenues of 5.784 billion yuan, 7.812 billion yuan, and 9.596 billion yuan for 2025-2027, with net profits of 900 million yuan, 1.336 billion yuan, and 1.616 billion yuan respectively [3] - The projected PE ratio for 2025 is 49X, maintaining a "recommended" rating [3]